SEC 13F Intelligence

Islet Management, LP / NTLA

Islet Management, LP’s Intellia Therapeutics Inc Position

Does Islet Management, LP own Intellia Therapeutics Inc (NTLA)? Not currently — the last reported position was 80.0K shares worth $13M in Q2 2021; the fund’s latest 13F (Q3 2023) no longer reports it.

Position Value
$13M
Q2 2021
Shares
80.0K
% of Portfolio
+0.36%
Quarters Held
1
position exited

Position History NTLA

Reported value by quarter
Q2 ’21: $13MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202180.0K$13M+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Islet Management, LP’s full portfolio or all institutional holders of NTLA.